Skip to main content
Top
Published in: Inflammation Research 7/2020

01-07-2020 | Kidney Injury | Original Researh Article

SIKIAT1/miR-96/FOXA1 axis regulates sepsis-induced kidney injury through induction of apoptosis

Authors: Shijun Lu, Haibin Wu, Jianhua Xu, Zhaofeng He, Haiyan Li, Chao Ning

Published in: Inflammation Research | Issue 7/2020

Login to get access

Abstract

Objective and design

Nowadays, sepsis-induced acute kidney injury (AKI) has gradually become a global problem for its high incidence and increasing mortality. Previous study has reported lncRNA ENST00000452391.1 in sepsis patients. However, its potential biological function and downstream molecular mechanism are still mysterious.

Methods and results

Our study found that it was upregulated in sepsis-induced AKI patients, so it was identified as “sepsis-induced kidney injury associated transcript 1 (SIKIAT1)”. We used lipopolysaccharide (LPS) stimulated HK-2 cells as an in vitro model to demonstrated that SIKIAT1 acts as a ceRNA for miR-96-3p to enhance FOXA1 expression and promote HK-2 cell apoptosis.

Conclusion

Therefore, it could be a potential biomarker and therapeutic target for sepsis-induced AKI in the development of disease.
Appendix
Available only for authorised users
Literature
18.
go back to reference Fu D, Zhou K, Liu J, Zheng P, Li P, Cheng W, et al. Long non-coding RNA PlncRNA-1 regulates cell proliferation, apoptosis, and autophagy in septic acute kidney injury by regulating BCL2. Int J Clin Exp Pathol. 2018;11(1):314–23.PubMedPubMedCentral Fu D, Zhou K, Liu J, Zheng P, Li P, Cheng W, et al. Long non-coding RNA PlncRNA-1 regulates cell proliferation, apoptosis, and autophagy in septic acute kidney injury by regulating BCL2. Int J Clin Exp Pathol. 2018;11(1):314–23.PubMedPubMedCentral
23.
go back to reference Katoh M, Katoh M. Human FOX gene family (Review). Int J Oncol. 2004;25(5):1495–500.PubMed Katoh M, Katoh M. Human FOX gene family (Review). Int J Oncol. 2004;25(5):1495–500.PubMed
Metadata
Title
SIKIAT1/miR-96/FOXA1 axis regulates sepsis-induced kidney injury through induction of apoptosis
Authors
Shijun Lu
Haibin Wu
Jianhua Xu
Zhaofeng He
Haiyan Li
Chao Ning
Publication date
01-07-2020
Publisher
Springer International Publishing
Published in
Inflammation Research / Issue 7/2020
Print ISSN: 1023-3830
Electronic ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-020-01350-0

Other articles of this Issue 7/2020

Inflammation Research 7/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.